Metabolomic correlates of coronary atherosclerosis, cardiovascular risk, both or neither. Results of the 2 × 2

Martino Deidda1, Antonio Noto1, Christian Cadeddu Dessalvi1

  • 1Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.

Insights

This study reveals distinct metabolic pathways linked to coronary artery disease (CAD) and cardiovascular risk factors (RFs). Specific metabolite patterns differentiate CAD presence/absence and high/low RF profiles, offering new insights into cardiovascular health.

Area of Science:

  • Metabolomics
  • Cardiovascular Disease Research
  • Biochemistry

Background:

  • Traditional cardiovascular risk factors (RFs) do not always correlate with coronary artery disease (CAD).
  • The CAPIRE study investigated functional-metabolic correlations in diverse patient phenotypes.
  • Understanding these discrepancies is crucial for personalized cardiovascular risk assessment.

Purpose of the Study:

  • To identify specific metabolic pathways associated with four distinct phenotypes: CAD with high/low RFs and no-CAD with high/low RFs.
  • To explore functional-metabolic correlations in coronary atherosclerosis.
  • To uncover novel risk factors and protective mechanisms in cardiovascular disease.

Main Methods:

  • Phenotypic classification of 241 subjects into four groups based on CAD presence/absence and RF burden (≥3 RFs vs ≤1 RF).
  • Metabolite profiling using gas chromatography-mass spectrometry.
  • Metabolite set enrichment analysis to identify associated pathways.

Main Results:

  • Distinct metabolic pathways were identified for each phenotype: amino sugars (CAD/high-RF), urea cycle (no-CAD/high-RF), glutathione (CAD/low-RF), and glycine/serine (no-CAD/low-RF).
  • CAD presence correlated with ammonia recycling; absence of CAD with mitochondrial acetyl group transfer.
  • Significant differences in phenylalanine metabolism pathways were observed between CAD/low-RF and no-CAD/low-RF groups.

Conclusions:

  • Specific metabolic pathways are uniquely associated with different combinations of CAD and RF profiles.
  • Novel functional insights were gained, particularly for low-RF CAD and asymptomatic high-risk individuals.
  • These findings highlight the complex interplay between metabolism and cardiovascular disease, suggesting new avenues for research and potential therapeutic targets.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
568
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
473
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
287
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
129
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
135
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
184